The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
white-paper
Bridging Discovery and Delivery
Read More
white-paper
Strategies for Accelerated CMC Development
Read More
case-study
Syner-G Helps Biotech Firm Successfully Advance Life-Saving Drug Through Manufacturing Startup and Clinical Trials
Read More
case-study
Advancing Biotech Drug Development: Syner-G BioPharma’s Collaborative Approach to Chemistry, Manufacturing, and Controls
Read More
Let's move from science to success.
Let’s Talk